MGMT and glioblastoma: However, approximately 60% of patients with GBM show resistance to temozolomide, since a nuclear enzyme, named O6-methylguanine-DNA methyltransferase (MGMT), removes alkyl groups from the O6-position of O6-methylguanine and returns the cell into the regular cell cycle mode.